# Differences in MicroRNA Expression in Firefighters Responding to a Train Derailment and Fire in East Palestine, Ohio

**Authors:** Jaclyn M. Goodrich, Yaodong Xin, Shawn C. Beitel, John Gulotta, Lu Wang, Bhavya Thotakura, Judith M. Graber, Derek Urwin, Alexander C. Mayer, Sara Jahnke, Derrick L. Edwards, Casey Grant, Sreenivasan Ranganathan, Jefferey L. Burgess

PMC · DOI: 10.3390/epigenomes10010008 · Epigenomes · 2026-02-03

## TL;DR

This study found that firefighters responding to a chemical fire had altered microRNA levels linked to cancer and other diseases.

## Contribution

The study identifies specific microRNA expression changes in firefighters after a single large-scale incident.

## Key findings

- 16 miRNAs showed higher expression in responding firefighters.
- Altered miRNAs were linked to cancer, vascular, and neurodegenerative diseases.
- Changes suggest non-transient biological impacts from acute exposure.

## Abstract

Background/Objectives: High-risk, low-frequency incidents such as building collapses and large chemical fires can result in acute, high-dose exposures to toxic agents for first responders and the surrounding community. While these exposures may last for hours to days, their contribution to firefighters’ risks for cancer and other diseases is relatively unknown. In February 2023, a freight train transporting chemicals derailed and caught fire in East Palestine, Ohio, US. More than 350 firefighters, primarily volunteer, responded to the incident. In this cross-sectional study, we evaluated epigenetic markers of toxicity in responding firefighters. We hypothesized that exposures from responding to the train derailment would alter the expression of microRNAs (miRNAs) linked to carcinogenesis. Methods: We enrolled 62 responding firefighters and a comparison group of 26 firefighters from the same region who did not respond to the incident. We measured the relative expression of 800 miRNAs in blood samples using the nCounter Human v3 miRNA expression panel. We compared the expression of miRNA between exposure groups in negative binomial regression models, adjusting for potential confounders. Results: At a false discover rate cut-off of 5% (q-value < 0.05), 16 miRNAs had significantly higher expression and one significantly lower among firefighters that responded to the incident. Top disease-related pathways in which these miRNAs were enriched included those relevant to neurodegenerative diseases, vascular disease, and multiple cancer sites. Conclusions: Overall, results suggest responding to one large incident can have non-transient impacts on miRNA expression. Whether this translates into longer-term health risks or adaptive responses to exposures is unclear.

## Linked entities

- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** MIR151B (microRNA 151b) [NCBI Gene 100616247], FASLG (Fas ligand) [NCBI Gene 356] {aka ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L}, MIR638 (microRNA 638) [NCBI Gene 693223] {aka MIRN638, hsa-mir-638}, MIR574 (microRNA 574) [NCBI Gene 693159] {aka MIR574-3p, MIRN574, hsa-mir-574, mir-574}, RGS17 (regulator of G protein signaling 17) [NCBI Gene 26575] {aka RGS-17, RGSZ2, hRGS17}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}
- **Diseases:** neurological disorders (MESH:D009461), renal cancer (MESH:D007680), hepatic angiosarcoma (MESH:D006394), burn (MESH:D002056), gastric cancer (MESH:D013274), carcinogenesis (MESH:D063646), Alzheimer's disease (MESH:D000544), lung cancer (MESH:D008175), vascular disease (MESH:D014652), lung diseases (MESH:D008171), Cancer (MESH:D009369), liver fibrosis (MESH:D008103), sleep disruption (MESH:D019958), lung function decline (MESH:D055370), injury to (MESH:D014947), neurodegeneration (MESH:D019636), prostate and thyroid cancers (MESH:D011471), melanoma (MESH:D008545), myeloid leukemia (MESH:D007951), dysplasia (MESH:D015792), hepatocellular carcinoma (MESH:D006528), esophageal tumors (MESH:D004938), bronchial premalignant lesions (MESH:D001982), cognitive impairment (MESH:D003072), glioblastoma multiforme (MESH:D005909), chromosomal damage (MESH:D025063), prostate carcinoma (MESH:D011472), explosion (MESH:D007174), breast cancer (MESH:D001943), dementia (MESH:D003704), ovarian cancer (MESH:D010051), toxicity (MESH:D064420), Fire (MESH:D000092422), metastasis (MESH:D009362), brain disease (MESH:D001927), thyroid carcinoma (MESH:D013964), carcinogenic (MESH:D011230), leukemia (MESH:D007938), colorectal carcinoma (MESH:D015179)
- **Chemicals:** volatile organic compounds (MESH:D055549), polycyclic aromatic hydrocarbon (MESH:D011084), Benzene (MESH:D001554), per- and polyfluoroalkyl substances (MESH:D005466), alcohol (MESH:D000438), Vinyl chloride (MESH:D014752), butyl acrylate (MESH:C032490), polyvinyl chloride (MESH:D011143), BTEX (-)
- **Species:** Nicotiana tabacum (American tobacco, species) [taxon 4097], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** Rs2910164, Rs3746444, Rs11614913

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12921792/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12921792/full.md

## References

51 references — full list in the complete paper: https://tomesphere.com/paper/PMC12921792/full.md

---
Source: https://tomesphere.com/paper/PMC12921792